Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
WSFS Financial | WSFS | Nov 22, 2024 | 60.48 | +3.01 |
WW International | WW | Nov 22, 2024 | 1.04 | +2.97 |
Wyndham Hotels & Resorts | WH | Nov 22, 2024 | 96.69 | +0.31 |
Wynn Resorts | WYNN | Nov 22, 2024 | 91.29 | -0.49 |
X Financial A ADR | XYF | Nov 22, 2024 | 6.30 | +0.80 |
X3 Holdings | XTKG | Nov 22, 2024 | 2.11 | +1 853.70 |
X4 Pharmaceuticals | XFOR | Nov 22, 2024 | 0.34 | -8.25 |
XAI Octagon Floating Rate & Alternative Income Term Trust | XFLT | Nov 22, 2024 | 6.96 | +0.87 |
XAI Octagon Floating Rate & Alternative Income Term Trust 20 | XFLT-A | Nov 22, 2024 | 25.09 | -0.28 |
XBiotech | XBIT | Nov 22, 2024 | 6.83 | +3.17 |
XBP Europe | XBP | Nov 22, 2024 | 1.26 | 0.00 |
Xcel Brands | XELB | Nov 22, 2024 | 0.69 | -0.01 |
Xcel Energy | XEL | Nov 22, 2024 | 71.35 | -0.04 |
XChange Tec.Inc ADR | XHG | Nov 22, 2024 | 1.47 | -2.00 |
XCHG Limited - ADS | XCH | Nov 22, 2024 | 13.30 | 0.00 |
Xencor | XNCR | Nov 22, 2024 | 25.01 | +3.78 |
Xenetic Biosciences | XBIO | Nov 22, 2024 | 4.11 | +2.30 |
Xenia Hotels & Resorts | XHR | Nov 22, 2024 | 15.33 | +2.06 |
Xenon Pharmaceuticals | XENE | Nov 22, 2024 | 41.15 | +3.39 |
Xeris Biopharma | XERS | Nov 22, 2024 | 3.09 | +1.64 |
Xerox | XRX | Nov 22, 2024 | 9.04 | +3.31 |
XIAO-I ADR | AIXI | Nov 22, 2024 | 5.95 | +2.59 |
Xilio Therapeutics | XLO | Nov 22, 2024 | 0.89 | -3.04 |
Xinyuan Real Estate ADR | XIN | Nov 22, 2024 | 3.34 | +3.73 |
XOMA | XOMA | Nov 22, 2024 | 30.20 | +0.43 |
XOMA A Pref | XOMAP | Nov 22, 2024 | 25.73 | +0.16 |
XOMA B Pref | XOMAO | Nov 22, 2024 | 25.25 | -0.31 |
Xometry A | XMTR | Nov 22, 2024 | 31.40 | +1.06 |
XORTX Therapeutics | XRTX | Nov 22, 2024 | 1.22 | -3.56 |
Xos | XOS | Nov 22, 2024 | 4.54 | +11.82 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.